A case report on the long-term survival of a patient with HER2-positive metastatic gastric adenocarcinoma and a short review of the current literature

被引：1

作者：

Puhr, Hannah Christina ^{[1
,2
]}

Ilhan-Mutlu, Ayseguel ^{[1
,2
]}

机构：

[1] Med Univ Vienna, Div Oncol, Dept Med 1, Vienna, Austria

[2] Med Univ Vienna, Upper Gastrointestinal Tumors Unit, Comprehens Canc Ctr Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria

来源：

MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2020年 / 13卷 / 04期

关键词：

Gastric cancer; Upper GI cancer; HER2; Trastuzumab; Ramucirumab; GASTROESOPHAGEAL JUNCTION CANCER; HER2; STATUS; OPEN-LABEL; TRASTUZUMAB; CHEMOTHERAPY; ESOPHAGEAL; PROGNOSIS;

D O I：

10.1007/s12254-020-00649-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The prognosis of patients with metastatic gastroesophageal cancer remains poor despite numerous promising clinical trials, and the clinical benefit of systemic therapies is under critical review. This case report of a patient with human epidermal growth factor receptor 2 (HER2)-positive metastatic gastric adenocarcinoma is an impulse for the importance of individual decision making and molecular guided treatment options.

引用

页码：453 / 458

页数：6

共 50 条

[1] A case report on the long-term survival of a patient with HER2-positive metastatic gastric adenocarcinoma and a short review of the current literature
Hannah Christina Puhr
Aysegül Ilhan-Mutlu
memo - Magazine of European Medical Oncology, 2020, 13 : 453 - 458
[2] Long term survival of a metastatic patient with pancreatic adenocarcinoma: a rare case report and review of the literature
Degirmenci, Mustafa
Varol, Umut
Ozguzer, Alp
Bozkurt, Mehmet
Sezgin, Canfeza
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2014, 29 (03): : 108 - 111
[3] Clinical predictors of long-term survival in HER2-positive metastatic breast cancer
Murthy, Pooja
Kidwell, Kelley M.
Schott, Anne F.
Merajver, Sofia D.
Griggs, Jennifer J.
Smerage, Jeffrey D.
Van Poznak, Catherine H.
Wicha, Max S.
Hayes, Daniel F.
Henry, N. Lynn
BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) : 589 - 595
[4] Clinical predictors of long-term survival in HER2-positive metastatic breast cancer
Pooja Murthy
Kelley M. Kidwell
Anne F. Schott
Sofia D. Merajver
Jennifer J. Griggs
Jeffrey D. Smerage
Catherine H. Van Poznak
Max S. Wicha
Daniel F. Hayes
N. Lynn Henry
Breast Cancer Research and Treatment, 2016, 155 : 589 - 595
[5] Prolonged Survival in Patients with Metastatic HER2-Positive Inflammatory Breast Cancer: A Case Report and Review of the Literature
Ge, Jennifer Y.
Overmoyer, Beth
CASE REPORTS IN ONCOLOGY, 2021, 14 (02): : 1071 - 1079
[6] LONG-TERM SURVIVAL IN HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES. CASE REPORT
Lazar, Diana
Funduianu, Diana
Baltig, E.
Ionescu, Dorina
Munteanu, Anca
MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2019, 123 (02): : 248 - 251
[7] Prolonged survival in a patient with metastatic HER2-positive inflammatory breast cancer: A case report
Xia, Yu
Luo, Jing
ASIAN JOURNAL OF SURGERY, 2024, 47 (11) : 4934 - 4936
[8] Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature
de Bernardi, Axel
Bachelot, Thomas
Larrouquere, Louis
FRONTIERS IN ONCOLOGY, 2024, 13
[9] Lower motor neuron syndrome in a patient with HER2-positive metastatic breast cancer: A case report and review of the literature
Diamanti, Luca
Quaquarini, Erica
Berzero, Giulia
Bini, Paola
Gastaldi, Matteo
Franciotta, Diego
Alfonsi, Enrico
Ceroni, Mauro
Frascaroli, Mara
Bernardo, Antonio
Marchioni, Enrico
CLINICAL NEUROLOGY AND NEUROSURGERY, 2018, 172 : 141 - 142
[10] Clinical predictors of long-term survival in Her2-positive (HER2+) metastatic breast cancer (MBC)
Murthy, Pooja
Kidwell, Kelley M.
Thomas, Dafydd G.
Griggs, Jennifer J.
Merajver, Sofia D.
Schott, Anne F.
Smerage, Jeffrey B.
Van Poznak, Catherine H.
Wicha, Max
Hayes, Daniel F.
Henry, N. Lynn
CANCER RESEARCH, 2015, 75

← 1 2 3 4 5 →